Cost Effectiveness of Treatments for non-ST-segment elevation Acute Coronary Syndrome

from Latest Results for PharmacoEconomics at http://bit.ly/1rOjUu4 on August 01, 2014 at 01:00AM Abstract Background Acute coronary syndrome (ACS) represents the most common subset of cardiovascular heart diseases and relates to high rates of morbidity and mortality worldwide and, consequently, to both the direct and indirect costs to the health system and society. Given the […]

The Four A’s of Expanding Access to Life-Saving Treatments and the Regulatory Implications

from Brookings Topics – Health at http://bit.ly/1s86ECx on July 31, 2014 at 08:27PM Please note that this Engelberg Center for Health Care Reform Health Policy Issue Brief first appeared in the Health Affairs Blog on July 31, 2014. Click here for the Health Affairs Blog version. Individual patient expanded access, sometimes termed “compassionate use,” refers to situations where access […]